CUTISS AG
PrivateLast Round
Series C
Sep 10, 2025
Total Funding Raised
$101.96M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
CUTISS AG operates in Healthcare & Life Sciences and is based in Schlieren. Its latest recorded funding round was a Series C round in September 2025.
CUTISS AG is a Swiss life sciences company that develops personalized, bio-engineered skin grafts to treat large and deep skin defects.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CUTISS AG Comparables
Compare CUTISS AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioLab Sciences | 80% | |
| PolarityBio, Inc. | 77% | |
| Keenova Therapeutics plc | 77% |
For institutional investors. Book with your work email.
CUTISS AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Sep 10, 2025 | ||||
| Grant | May 2, 2023 | ||||
| Series B | Jun 29, 2020 | ||||
| Grant | Aug 19, 2019 | ||||
| Grant | Sep 1, 2018 | ||||
Series A | Jun 20, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
CUTISS AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Union's Horizon Research and Innovation program | Grant |
| European Commission | Grant |
| Yellowstone Holding AG | Series A |
| Swisspreneur Syndicate | Series C |
| Wyss Foundation | Series B |
| Innosuisse | Grant |
| University of Zurich | Convertible Debt |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 64% MoM.
- Jul 26, 2026
Monthly visitors grew 166% MoM, reaching 6.9K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_awardOct 29, 2026
Daniela Marino, CEO of Cutiss AG, receives the 2026 EY Entrepreneur Of The Year award in the “Scale-up Leaders” category for Biotechnology & Healthcare from EY, recognizing her vision and dedication to bringing scientific innovation into meaningful medical applications.
For institutional investors. Book with your work email.
CUTISS AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CUTISS AG's valuation, stock price, and market status.
Is CUTISS AG a public or private company?
CUTISS AG is a private company.
What is the current stock price of CUTISS AG?
CUTISS AG is a private company, so its shares have no public market price. Caplight tracks CUTISS AG's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CUTISS AG worth (valuation)?
Valuation information for CUTISS AG is not publicly available.
Can I buy CUTISS AG stock?
CUTISS AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CUTISS AG's last funding round?
CUTISS AG's most recent funding round was Series C on September 10, 2025.
Who are the main investors in CUTISS AG?
Key investors in CUTISS AG include European Union's Horizon Research and Innovation program, University of Zurich, Shiloh Advisors AG, Innosuisse.
Will CUTISS AG IPO soon?
No public IPO plans have been announced for CUTISS AG.
How can I track CUTISS AG secondary market activity?
Caplight tracks bids, offers, and trades in CUTISS AG's shares on secondary markets.